https://www.selleckchem.com/pr....oducts/pd-1-pd-l1-in
BACKGROUND Clinical trials are expensive and often require funding from the pharmaceutical industry (PI). We aimed to compare studies funded by the PI with studies funded by other sources in terms of costs, reported results and strength of evidence. METHODS We searched PubMed for clinical trial reports on metastatic NSCLC published between 2012 and 2017. We divided all studies into two groups studies funded by the PI or by other sources. The primary endpoint was to compare the evidence strength of each group. Secondary en
Beğen
Yorum Yap
Paylaş
